Point72 Asset Management L.P. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 4:31 pm Sale |
2021-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Point72 Asset Management L.P. | 44 0.100% |
-27,798![]() (-99.84%) |
Filing |
2021-05-18 4:30 pm Purchase |
2021-05-17 | 13G | Forte Biosciences, Inc. FBRX |
Point72 Asset Management L.P. | 27,842 5.200% |
27,842![]() (New Position) |
Filing |